Balyasny Asset Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-49,250
Closed -$3.85M 2167
2024
Q4
$3.85M Buy
+49,250
New +$3.85M 0.01% 926
2024
Q2
Sell
-90,674
Closed -$7.74M 2114
2024
Q1
$7.74M Buy
90,674
+44,728
+97% +$3.82M 0.01% 759
2023
Q4
$3.93M Buy
+45,946
New +$3.93M 0.01% 848
2023
Q3
Sell
-54,733
Closed -$4.66M 1942
2023
Q2
$4.66M Sell
54,733
-98,229
-64% -$8.36M 0.01% 801
2023
Q1
$12.7M Buy
+152,962
New +$12.7M 0.03% 543
2022
Q4
Sell
-243,677
Closed -$18M 2478
2022
Q3
$18M Sell
243,677
-302,999
-55% -$22.4M 0.06% 382
2022
Q2
$35.6M Buy
+546,676
New +$35.6M 0.12% 191
2022
Q1
Sell
-355,127
Closed -$18.8M 2269
2021
Q4
$18.8M Buy
355,127
+14,311
+4% +$759K 0.06% 365
2021
Q3
$24.1M Buy
340,816
+328,682
+2,709% +$23.2M 0.1% 249
2021
Q2
$809K Buy
+12,134
New +$809K ﹤0.01% 1183
2021
Q1
Sell
-164,944
Closed -$19.6M 1701
2020
Q4
$19.6M Sell
164,944
-97,076
-37% -$11.5M 0.11% 237
2020
Q3
$22.9M Buy
262,020
+135,596
+107% +$11.8M 0.17% 143
2020
Q2
$11.3M Buy
+126,424
New +$11.3M 0.1% 263
2020
Q1
Sell
-175,119
Closed -$20.1M 1166
2019
Q4
$20.1M Buy
+175,119
New +$20.1M 0.12% 245
2019
Q2
Sell
-8,846
Closed -$774K 1416
2019
Q1
$774K Buy
+8,846
New +$774K 0.01% 985
2018
Q3
Sell
-4,953
Closed -$444K 1568
2018
Q2
$444K Buy
+4,953
New +$444K ﹤0.01% 1205
2017
Q4
Sell
-7,730
Closed -$347K 1866
2017
Q3
$347K Sell
7,730
-58,570
-88% -$2.63M ﹤0.01% 1265
2017
Q2
$2.62M Buy
+66,300
New +$2.62M 0.01% 722